Clinical advances in pediatric nonalcoholic fatty liver disease.
作者信息
Schwimmer Jeffrey B
机构信息
Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California, San Diego School of Medicine, La Jolla, CA.
Department of Gastroenterology, Rady Children's Hospital San Diego, San Diego, CA.
出版信息
Hepatology. 2016 May;63(5):1718-25. doi: 10.1002/hep.28441. Epub 2016 Mar 4.
Abstract
摘要
相似文献
1
Clinical advances in pediatric nonalcoholic fatty liver disease.儿童非酒精性脂肪性肝病的临床进展
Hepatology. 2016 May;63(5):1718-25. doi: 10.1002/hep.28441. Epub 2016 Mar 4.
2
There's more under the nonalcoholic fatty liver disease umbrella than an elevated alanine aminotransferase level.在非酒精性脂肪性肝病范畴内，情况比单纯丙氨酸氨基转移酶水平升高更为复杂。
J Pediatr. 2014 Apr;164(4):684-6. doi: 10.1016/j.jpeds.2013.12.026. Epub 2014 Jan 23.
3
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications.超声在非酒精性脂肪性肝病及其并发症的诊断与治疗中的作用。
Expert Rev Gastroenterol Hepatol. 2015 May;9(5):603-27. doi: 10.1586/17474124.2015.1007955. Epub 2015 Feb 19.
4
Decision making for liver biopsy in NASH, not so FAST?非酒精性脂肪性肝炎（NASH）肝活检的决策制定，没那么快？
Lancet Gastroenterol Hepatol. 2020 Apr;5(4):332-334. doi: 10.1016/S2468-1253(19)30406-6. Epub 2020 Feb 3.
5
Nonalcoholic fatty liver disease and cardiovascular risk: is there a place for obstructive sleep apnea?非酒精性脂肪性肝病与心血管风险：阻塞性睡眠呼吸暂停在其中有影响吗？
Can J Cardiol. 2013 Sep;29(9):1139.e7. doi: 10.1016/j.cjca.2012.10.019. Epub 2012 Dec 21.
6
Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease.血清丙氨酸氨基转移酶可预测非酒精性脂肪性肝病患者的室间隔厚度和左心室质量。
Eur J Gastroenterol Hepatol. 2014 Jun;26(6):654-60. doi: 10.1097/MEG.0000000000000086.
7
Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance.阻塞性睡眠呼吸暂停综合征可影响非酒精性脂肪性肝病患儿的肝组织学和炎症细胞激活，而与肥胖/胰岛素抵抗无关。
Am J Respir Crit Care Med. 2014 Jan 1;189(1):66-76. doi: 10.1164/rccm.201307-1339OC.
8
Important issues for selecting patients with nonalcoholic fatty liver disease: a biochemical view.选择非酒精性脂肪性肝病患者的重要问题：生化视角
Eur J Gastroenterol Hepatol. 2014 Aug;26(8):937. doi: 10.1097/MEG.0000000000000137.
9
Obstructive sleep apnoea is common in adults with biopsy-proven non-alcoholic fatty liver disease.在经活检证实患有非酒精性脂肪性肝病的成年人中，阻塞性睡眠呼吸暂停很常见。
Sleep Med. 2015 Aug;16(8):1026. doi: 10.1016/j.sleep.2015.04.003. Epub 2015 Apr 20.
10
The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.非肥胖非糖尿病土耳其人群中胰岛素抵抗、代谢综合征与非酒精性脂肪性肝病之间的关系：一项初步研究。
Turk J Gastroenterol. 2014 Dec;25 Suppl 1:63-8. doi: 10.5152/tjg.2014.6233.
引用本文的文献
1
Controlled attenuation parameter (CAP): the clinical value based on MRI-PDFF in children with obesity.受控衰减参数（CAP）：基于磁共振成像-质子密度脂肪分数（MRI-PDFF）在肥胖儿童中的临床价值。
J Pediatr Endocrinol Metab. 2024 May 10;37(7):605-612. doi: 10.1515/jpem-2023-0566. Print 2024 Jul 26.
2
Evaluation of the feasibility of screening for paediatric non-alcoholic fatty liver disease.评估小儿非酒精性脂肪肝疾病筛查的可行性。
Acta Paediatr. 2022 Dec;111(12):2408-2415. doi: 10.1111/apa.16502. Epub 2022 Aug 7.
3
Possible prediction of obesity-related liver disease in children and adolescents using indices of body composition.利用身体成分指数预测儿童和青少年肥胖相关肝病。
Pediatr Obes. 2022 Oct;17(10):e12947. doi: 10.1111/ijpo.12947. Epub 2022 Jun 21.
4
Distinctive Features of Hepatic Steatosis in Children: Is It Primary or Secondary to Inborn Errors of Metabolism?儿童肝脂肪变性的显著特征：它是原发性的还是代谢先天性缺陷继发的？
Pediatr Gastroenterol Hepatol Nutr. 2021 Nov;24(6):518-527. doi: 10.5223/pghn.2021.24.6.518. Epub 2021 Nov 5.
5
Prevalence of increased transaminases and its association with sex, age, and metabolic parameters in children and adolescents with obesity - a nationwide cross-sectional cohort study.肥胖儿童和青少年转氨酶升高的患病率及其与性别、年龄和代谢参数的关联——一项全国性横断面队列研究
BMC Pediatr. 2021 Jun 9;21(1):271. doi: 10.1186/s12887-021-02747-4.
6
Incidence of Nonalcoholic Fatty Liver Disease in Children: 2009-2018.儿童非酒精性脂肪性肝病的发病率：2009-2018 年。
Pediatrics. 2020 Dec;146(6). doi: 10.1542/peds.2020-0771.
7
Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome.血管生成素样蛋白 8（ANGPTL8）可作为普拉德-威利综合征患儿非酒精性脂肪性肝病的潜在预测因子。
J Endocrinol Invest. 2021 Jul;44(7):1447-1456. doi: 10.1007/s40618-020-01444-w. Epub 2020 Oct 16.
8
Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease.重度肥胖与儿童非酒精性脂肪性肝病的肝脏疾病严重程度相关。
Pediatr Obes. 2020 Feb;15(2):e12581. doi: 10.1111/ijpo.12581. Epub 2019 Oct 27.
9
Pediatric Fatty Liver Disease.小儿脂肪肝疾病
Mo Med. 2019 Mar-Apr;116(2):123-128.
10
Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard.基于 MRI-PDFF 作为金标准的儿童肝脂肪变性的受控衰减参数快速评估。
BMC Pediatr. 2019 Apr 15;19(1):112. doi: 10.1186/s12887-019-1485-8.
本文引用的文献
1
Weight Loss and Health Status 3 Years after Bariatric Surgery in Adolescents.青少年接受减肥手术后3年的体重减轻及健康状况
N Engl J Med. 2016 Jan 14;374(2):113-23. doi: 10.1056/NEJMoa1506699. Epub 2015 Nov 6.
2
Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease.用于非酒精性脂肪性肝病中脂肪变性诊断的受控衰减参数
J Gastroenterol Hepatol. 2016 Apr;31(4):848-55. doi: 10.1111/jgh.13219.
3
Liver transplantation for nonalcoholic steatohepatitis in young patients.年轻患者非酒精性脂肪性肝炎的肝移植
Transpl Int. 2016 Apr;29(4):418-24. doi: 10.1111/tri.12694.
4
Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy.使用FibroScan的XL探头通过受控衰减参数（CAP）评估肝脂肪变性：一项评估诊断准确性的初步研究
Ultrasound Med Biol. 2016 Jan;42(1):92-103. doi: 10.1016/j.ultrasmedbio.2015.08.008. Epub 2015 Sep 19.
5
High Prevalence of Nonalcoholic Fatty Liver Disease in Adolescents Undergoing Bariatric Surgery.接受减肥手术的青少年中非酒精性脂肪性肝病的高患病率。
Gastroenterology. 2015 Sep;149(3):623-34.e8. doi: 10.1053/j.gastro.2015.05.039. Epub 2015 May 28.
6
Paediatric gastroenterology. On a knife-edge--weight-loss surgery for NAFLD in adolescents.儿科胃肠病学。处于关键边缘——青少年非酒精性脂肪性肝病的减肥手术。
Nat Rev Gastroenterol Hepatol. 2015 Jun;12(6):316-8. doi: 10.1038/nrgastro.2015.59. Epub 2015 Apr 14.
7
Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart Study.肝脂肪变性与心血管疾病结局：弗雷明汉心脏研究分析
J Hepatol. 2015 Aug;63(2):470-6. doi: 10.1016/j.jhep.2015.02.045. Epub 2015 Mar 14.
8
Indications and limitations of bariatric intervention in severely obese children and adolescents with and without nonalcoholic steatohepatitis: ESPGHAN Hepatology Committee Position Statement.重度肥胖儿童及青少年（伴或不伴非酒精性脂肪性肝炎）减肥干预的适应症与局限性：欧洲儿科胃肠病、肝病和营养学会肝病委员会立场声明
J Pediatr Gastroenterol Nutr. 2015 Apr;60(4):550-61. doi: 10.1097/MPG.0000000000000715.
9
The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患儿肝纤维化评分的评估
Dig Dis Sci. 2015 May;60(5):1440-7. doi: 10.1007/s10620-014-3494-7. Epub 2014 Dec 25.
10
Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease.磁共振成像和肝脏组织学作为非酒精性脂肪性肝病患儿肝脂肪变性的生物标志物
Hepatology. 2015 Jun;61(6):1887-95. doi: 10.1002/hep.27666. Epub 2015 Feb 5.
Zotero 插件